CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenues	$ 0	$ 106,095	$ 1,256,608	$ 1,674,275
Operating Expenses
Cost of revenues	0	35,736	370,492	356,750
Patent amortization expense	0	377,746	503,660	1,133,235
General and administrative	711,047	1,620,311	2,788,060	5,006,810
Total operating expenses	711,047	2,033,793	3,662,212	6,496,795
Loss from operations	(711,047)	(1,927,698)	(2,405,604)	(4,822,520)
Other income (expense)
Gain on debt extinguishment	0	0	40,802,730	2,434,661
Decrease in fair value of derivative liabilities	0	330	0	948
Interest expense, net	(97,385)	(867,713)	(2,070,927)	(2,867,741)
Total other income (expense), net	(97,385)	(867,383)	38,731,803	(432,132)
Net income (loss)	(808,432)	(2,795,081)	36,326,199	(5,254,652)
Deemed dividend on preferred stock	0	0	0	(466,667)
Net income (loss) attributable to common shareholders	$ (808,432)	$ (2,795,081)	$ 36,326,199	$ (5,721,319)
Basic income (loss) per share	$ (0.05)	$ (0.57)	$ 2.61	$ (1.26)
Fully diluted income (loss) per share	$ (0.05)	$ (0.57)	$ 0.67	$ (1.26)
Weighted average shares outstanding:
Basic	16,868,702	4,910,740	13,911,880	4,529,568
Fully diluted	16,868,702	4,910,740	54,184,893	4,529,568